Post-approval studies (Phase 4)Not Yet RecruitingNCT07652515
What this trial is testing
Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial Cancer
Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 100